Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sibylle Cocciardi

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Leukemia|May 16, 2019
getITD for FLT3-ITD-based MRD monitoring in AMLTamara J Blätte, Laura K Schmalbrock, Sabrina Skambraks, et al.
Blood Advances|March 8, 2021
Deregulated expression of circular RNAs in acute myeloid leukemiaSusanne Lux, Tamara J Blätte, Bernhard Gillissen, et al.
American Journal of Human Genetics|March 9, 2010
DNA methylome of familial breast cancer identifies distinct profiles defined by mutation statusJames M Flanagan, Sibylle Cocciardi, Nic Waddell, et al.
The Journal of Pathology|July 2, 2010
Gene expression profiling of formalin-fixed, paraffin-embedded familial breast tumours using the whole genome-DASL assayNic Waddell, Sibylle Cocciardi, Julie Johnson, et al.
Breast Cancer Research and Treatment|June 22, 2012
Gene expression profiling of tumour epithelial and stromal compartments during breast cancer progressionAna Cristina Vargas, Amy E McCart Reed, Nic Waddell, et al.
Haematologica|October 4, 2017
Circular RNAs of the nucleophosmin (NPM1) gene in acute myeloid leukemiaSusanne Hirsch, Tamara J Blätte, Sarah Grasedieck, et al.
Plos One|May 14, 2015
Using the MCF10A/MCF10CA1a Breast Cancer Progression Cell Line Model to Investigate the Effect of Active, Mutant Forms of EGFR in Breast Cancer Development and Treatment Using GefitinibDarrell C Bessette, Erik Tilch, Tatjana Seidens, et al.
Hemasphere|January 16, 2025
Impact of myelodysplasia-related and additional gene mutations in intensively treated patients with <i>NPM1</i>-mutated AMLSibylle Cocciardi, Maral Saadati, Nina Weiß, et al.
Breast Cancer Research and Treatment|February 23, 2018
Characterization of a novel breast cancer cell line derived from a metastatic bone lesion of a breast cancer patientJulie Johnson, Darrell C Bessette, Jodi M Saunus, et al.
Blood Advances|December 22, 2020
Genomic heterogeneity in core-binding factor acute myeloid leukemia and its clinical implicationNikolaus Jahn, Tobias Terzer, Eric Sträng, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Leukemia|May 16, 2019
getITD for FLT3-ITD-based MRD monitoring in AMLTamara J Blätte, Laura K Schmalbrock, Sabrina Skambraks, et al.
Blood Advances|March 8, 2021
Deregulated expression of circular RNAs in acute myeloid leukemiaSusanne Lux, Tamara J Blätte, Bernhard Gillissen, et al.
American Journal of Human Genetics|March 9, 2010
DNA methylome of familial breast cancer identifies distinct profiles defined by mutation statusJames M Flanagan, Sibylle Cocciardi, Nic Waddell, et al.
The Journal of Pathology|July 2, 2010
Gene expression profiling of formalin-fixed, paraffin-embedded familial breast tumours using the whole genome-DASL assayNic Waddell, Sibylle Cocciardi, Julie Johnson, et al.
Breast Cancer Research and Treatment|June 22, 2012
Gene expression profiling of tumour epithelial and stromal compartments during breast cancer progressionAna Cristina Vargas, Amy E McCart Reed, Nic Waddell, et al.
Haematologica|October 4, 2017
Circular RNAs of the nucleophosmin (NPM1) gene in acute myeloid leukemiaSusanne Hirsch, Tamara J Blätte, Sarah Grasedieck, et al.
Plos One|May 14, 2015
Using the MCF10A/MCF10CA1a Breast Cancer Progression Cell Line Model to Investigate the Effect of Active, Mutant Forms of EGFR in Breast Cancer Development and Treatment Using GefitinibDarrell C Bessette, Erik Tilch, Tatjana Seidens, et al.
Hemasphere|January 16, 2025
Impact of myelodysplasia-related and additional gene mutations in intensively treated patients with <i>NPM1</i>-mutated AMLSibylle Cocciardi, Maral Saadati, Nina Weiß, et al.
Breast Cancer Research and Treatment|February 23, 2018
Characterization of a novel breast cancer cell line derived from a metastatic bone lesion of a breast cancer patientJulie Johnson, Darrell C Bessette, Jodi M Saunus, et al.
Blood Advances|December 22, 2020
Genomic heterogeneity in core-binding factor acute myeloid leukemia and its clinical implicationNikolaus Jahn, Tobias Terzer, Eric Sträng, et al.
Pageof 2